Study to Evaluate Efficacy/Safety of 4 Doses of CHF5259 Via Dry Powder Inhaler (DPI) in Patients With COPD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The study was designed to investigate the efficacy and safety of different doses CHF5259 a long acting muscarinic antagonist in patients with moderate to severe COPD.
Epistemonikos ID: 7c245b8f98796295ac35cc76ea45ec53546039fa
First added on: May 12, 2024